Skip to main content
. 2013 Jun;98(6):937–944. doi: 10.3324/haematol.2012.067983

Figure 2.

Figure 2.

Drug cytotoxicity of RAS-mutated and non-mutated infant ALL patients. (A) In vitro prednisolone cytotoxicity in MLL-rearranged infant ALL patients, (B) In vitro dexamethasone cytotoxicity in MLL-rearranged infant ALL patients, (C) In vitro prednisolone cytotoxicity in t(4;11)-rearranged infant ALL patients, (D) In vitro dexamethasone cytotoxicity in t(4;11)-rearranged infant ALL patients. Mean in vitro cytotoxicity responses in RAS-mutated and non-mutated infant ALL patients were statistically analyzed using Mann-Whitney U-test. Error bars represent standard error of the mean. Cytotoxicity data for prednisolone and dexamethasone was available for 63 and 44 MLL-rearranged infants ALL patients and 26 and 18 t(4;11)-rearranged infants, respectively.